Medicare drug plans would have to let any qualified pharmacy join their network under fair standard terms. PBMs would face new limits on what money they can keep and new reporting, audit, and penalty rules starting in 2028.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Patients Before Middlemen Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.
Latest action on S. 882: Read twice and referred to the Committee on Finance.
Who this affects: This bill mainly affects people with Medicare drug coverage, pharmacies, PBMs, Medicare drug plans, and federal health officials. Patients could have more pharmacy options. Local and independent pharmacies could have a clearer path into plan networks. PBMs and plans would face stricter payment, reporting, audit, and enforcement rules.
Why this matters: This bill matters because Medicare patients may lose pharmacy options when plan networks are narrow or local pharmacies cannot accept the terms. The bill tries to make pharmacy access clearer and gives local pharmacies more ways to stay in networks. It also tries to show how money moves among drugmakers, PBMs, plans, and pharmacies. The bill does not directly set drug prices or cap what patients pay at the pharmacy counter, so the final effect on costs is uncertain.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
